{"schema_version":"1","generated_at":"2026-10-30T23:50:27.449Z","data_as_of":null,"url":"https://www.findmykol.com/kol/sadhna-vora","json_url":"https://www.findmykol.com/kol/sadhna-vora/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"sadhna-vora","name":"Sadhna Vora","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Massachusetts General Hospital","institution_url":"https://www.findmykol.com/institution/massachusetts-general-hospital","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1235266685","openalex":"A5086182006"},"summary":"Sadhna Vora is an Oncology physician affiliated with Massachusetts General Hospital. OpenAlex indexes 10 publications with 1,218 citations (h-index 6).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":10,"cited_by_count":1218,"h_index":6,"latest_activity_year":2015,"source":"works"},"publications":{"total":10,"shown":5,"withheld":5,"matched_by":"OpenAlex author record","recent":[{"title":"Abstract P1-13-03: Association of PIK3CA mutation with clinical response to specific endocrine therapies in metastatic hormone receptor positive (HR+) breast cancer","year":2015,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.sabcs14-p1-13-03","status":"verified"},{"title":"CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors","year":2014,"journal":"Cancer Cell","source_url":"https://doi.org/10.1016/j.ccr.2014.05.020","status":"verified"},{"title":"mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in <i>PIK3CA</i> -Mutant Breast Cancer","year":2013,"journal":"Science Translational Medicine","source_url":"https://doi.org/10.1126/scitranslmed.3005747","status":"verified"},{"title":"Abstract PR02: LEE011: An orally bioavailable, selective small molecule inhibitor of CDK4/6– Reactivating Rb in cancer.","year":2013,"journal":"Molecular Cancer Therapeutics","source_url":"https://doi.org/10.1158/1535-7163.targ-13-pr02","status":"verified"},{"title":"Abstract B106: mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer.","year":2013,"journal":"Molecular Cancer Therapeutics","source_url":"https://doi.org/10.1158/1535-7163.targ-13-b106","status":"verified"}],"source":"works"},"similar":[{"name":"Keith Flaherty","slug":"keith-flaherty","institution":"Massachusetts General Hospital","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/keith-flaherty","json_url":"https://www.findmykol.com/kol/keith-flaherty/profile.json"},{"name":"James Januzzi","slug":"james-januzzi","institution":"Massachusetts General Hospital","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/james-januzzi","json_url":"https://www.findmykol.com/kol/james-januzzi/profile.json"},{"name":"Maurizio Fava","slug":"maurizio-fava","institution":"Massachusetts General Hospital","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/maurizio-fava","json_url":"https://www.findmykol.com/kol/maurizio-fava/profile.json"},{"name":"Steven Greenberg","slug":"steven-greenberg","institution":"Massachusetts General Hospital","specialty":"Neurology","url":"https://www.findmykol.com/kol/steven-greenberg","json_url":"https://www.findmykol.com/kol/steven-greenberg/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":5}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}